New Discovery
BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.
New Scientific Advisory Board
BioMark would like to introduce and welcome 2 new members to its scientific advisory board. The new members are: Dr. Samudra Dissanayake, Director Strategic Initiatives and Business Development Health-Tech-Connex Dr. Dissanayake has been an important contributor in the development of BioMark’s technology platform for cancer screening, response to treatment and cancer treatment. Dr. Dissanayake role […]
